StaffAndrew Cant

Andrew Cant

eap 2017, Andrew Cant, vaccination

Professor Cant has practiced medicine for 36 years. After training in internal medicine, infectious diseases, paediatrics and neonatology at St George’s and Guy’s Hospitals in London, Professor Cant held a Medical Research Council Fellowship in immunology before completing his training in paediatric immunology and infectious diseases at the Hospital for Sick Children, Great Ormond Street, London and L’Hôpital Necker, Paris. In 1990, Professor Cant was appointed as a Consultant in Newcastle, to set up 1 of 2 national referral centres for the treatment of children with severe immunological disorders, and a regional paediatric infectious diseases service. The service has grown and the Unit is now recognised as a world leader for radical curative treatments for childhood immune disorders.

Professor Cant has been awarded grants of over £8 million to support research into childhood tuberculosis, meningococcal disease, the epidemiology and pathology of primary immune deficiencies and bone marrow transplantation for primary immune deficiencies; leading to over 200 peer reviewed papers and 20 chapters.

Since 1999 Professor Cant has been a member of the European Society for Immunodeficiencies (ESID) Board. In 2012 he was honoured to be elected President of ESID. ESID is the foremost Society worldwide, fostering research, education and innovation in the treatment of patients with primary immunodeficiencies. From 2006 to 2009 Professor Cant was President of the European Society for Paediatric Infectious Diseases (ESPID). During this time he developed multicentre research on childhood infections, on-line resources to University Diploma level for postgraduate training and acceptance of paediatric infectious diseases as a recognised subspecialty within The European Union of Medical Specialties. He is also a member of the Medical Advisory Board of the International Patient Organisation for Primary Immunodeficiencies (IPOPI).